期刊文献+

哇巴因通过阻遏激光激酶信号途径抑制肝癌细胞生长机制探索 被引量:2

The mechanism study of ouabain in inhibiting the growth of hepatocellular carcinoma cells by inhibiting the laser kinase signaling pathway
原文传递
导出
摘要 目的观察钠钾ATP酶抑制剂哇巴因抑制肝癌HepG2细胞的增殖和分裂效果,并探讨其作用机制。方法不同浓度(0.1、1.0、10.0μmol/L)哇巴因作用HepG2细胞24 h,以HepG2细胞为对照组,通过细胞活力检测试剂盒(CCK-8法)检测哇巴因对HepG2细胞增殖的抑制作用,细胞免疫荧光共定位(ICC法)检测细胞染色体分离状态,Western印迹检测极光激酶A(AURKA)、雷帕霉素靶蛋白(mTOR)、p-mTOR、促分裂原活化蛋白激酶(ERK)、p-ERK蛋白表达。结果0.1、1、10μmol/L哇巴因作用细胞24 h后,细胞生长抑制率分别为(23.50±4.57)%、(49.80±5.32)%和(72.10±5.62)%,与对照组相比差异均有统计学意义,抑制效果呈现浓度依赖性(F=32.8,均P<0.05);细胞免疫荧光共定位显示,1μmol/L哇巴因作用细胞24 h后,染色体分离发生障碍。与对照组相比,加药组细胞纺锤体直径显著较低,差异有统计学意义(t=9.58,P<0.05)。Western印迹结果显示,1μmol/L哇巴因作用HepG2细胞24 h后,与对照组相比,AURKA、p-mTOR、p-ERK表达较低(F=16.26,8.32,33.59;P<0.05),哇巴因可阻抑肝癌细胞在裸鼠体内生长(F=370.20,P<0.05)。结论哇巴因通过阻遏激光激酶信号途径,诱发肝癌HepG2细胞染色体分裂障碍、抑制肝癌细胞生长。 Objective To investigate the effect of Na+/K+-ATPase inhibitor ouabain on the proliferation and division of liver cancer HepG2 cells,and to explore the anticancer mechanism.Methods HepG2 cells were exposed with different concentrations of ouabain(0.1,1,10μmol/L)for 24 h,the proliferation ability was appraised using CCK-8,and the HepG2 cells was as a control group.The status of chromosome separation was detected with cell immunofluorescence(ICC)coupled to confocal microscope.The expression levels of AURKA,mTOR,p-mTOR,ERK and p-ERK protein were analyzed using western blot.Results After treating with 0.1,1 and 10μmol/L of ouabain for 24 h,the inhibitory rate of cells were(23.5±4.57)%,(49.80±5.32)%,and(72.10±5.62)%,respectively.Ouabain could significantly inhibit the proliferation of HepG2,and presented in a dose-dependent manner(F=32.8,P<0.05).The ICC results showed that the chromosome separation disorders occurred in HepG2 cells treated with 1μmol/L for 24 h,and the spindle diameter of HepG2 cells with ouabain treatment was decreased significantly compared with the control group(t=9.58,P<0.05).The results of western blot showed that the expression levels of AURKA,p-mTOR and p-ERK expressions in HepG2 cells treated with 1μmol/L of ouabain were significantly decreased compared with the control group(F=16.26,8.32,33.59,P<0.05).Ouabain inhibited the growth of hepatocellular carcinoma cells in nude mice(F=370.20,P<0.05).Conclusion Ouabain can induce chromosome division disorder and inhibit the proliferation in liver cancer HepG2 cells by inhibiting AURKA signaling pathway.
作者 付丽娜 徐忠伟 徐瑞成 方涛 王凤梅 Fu Lina;Xu Zhongwei;Xu Ruicheng;Fang Tao;Wang Fengmei(Department of Gastroenterology,Tianjin Fourth Central Hospital,Tianjin 300140,China;Central Laboratory of Armed Police Logistics College,Tianjin 300309,China;Department of Hepatology,Tianjin Second People′s Hospital,Tianjin 300211,China)
出处 《中华医学杂志》 CAS CSCD 北大核心 2020年第38期3014-3017,共4页 National Medical Journal of China
基金 国家自然科学基金(81673651) 天津市自然科学基金(18JCZDJC36500)。
关键词 肝细胞 哇巴因 细胞增殖 细胞分裂 极光激酶 Carcinoma,Hepatocellular Ouabain Cell proliferation Cell division Aurora kinase
  • 相关文献

参考文献2

二级参考文献23

  • 1Bell DR, Van Zant G. Stem cells, aging, and cancer: inevitabihties and outcomes. Oncogene, 2004,23 (43) : 7290- 7296.
  • 2Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival[ J]. Cell, 2003, 115 (5) : 577-590.
  • 3Bange J, Prechtl D, Cheburkin Y, et al. Cancer progression and tumor cell motility are associated with the FGFR4 Arg( 388 ) allele [J]. Cancer Res, 2002, 62(3) : 840-847.
  • 4Koziczak M, T Holbro, NE Hynes. Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyelins [ j 1. Oncogene, 2004, 23 (20) :3501-3508.
  • 5Basso AD, Mirza A, Liu G, et al. The farnesyl transferase inhibitor ( FTI ) SCH66336 ( lonafarnib ) inhibits Rheb famesylation and roTOR signaling. Role in FTI enhancement of taxaue and tamoxifen anti-tumor activity[ J]. J Biol Chem, 2005, 280(35) : 31101-31108.
  • 6Urano J, Sato T, Matsuo T, et al. Point mutations in TOR confer Rheb-independent growth in fission yeast and nutrient-independent mammalian TOR signaling in mammalian cells [ J ]. Proc NadAead Sci USA, 2007,104(9) : 3514-3519.
  • 7Jiang WG, Sampason J, Martin TA, et al. Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes[ J]. Eur J Cancer, 2005, 41 ( 11 ) : 1628-1636.
  • 8Yang TL, Su YR, Huang CS, et al. High-resolution 19p13.2- 13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity [ J] . Genes Chromosomes Cancer, 2004, 41 (3) : 250-256.
  • 9Fenton H, Carlile B, Montgomery EA, et al. LKB1 protein expression in human breast cancer [ J ]. Appl Immunohistochem Mol Morphol, 2006, 14(2) :146-153.
  • 10Wu GJ, Sinclair CS, Paape J, et al. 17q23 amplifications in breast cancer involve the PAT1, RAD51 C, PS6K, and SIGmal B genes[ J]. Cancer Res, 2000, 60(19) :5371-5375.

共引文献13

同被引文献20

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部